annual D&A:
$56.67M+$2.62M(+4.84%)Summary
- As of today (August 25, 2025), ALNY annual depreciation & amortization is $56.67 million, with the most recent change of +$2.62 million (+4.84%) on December 31, 2024.
- During the last 3 years, ALNY annual D&A has fallen by -$33.02 million (-36.82%).
- ALNY annual D&A is now -36.82% below its all-time high of $89.69 million, reached on December 31, 2021.
Performance
ALNY Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$13.94M-$461.00K(-3.20%)Summary
- As of today (August 25, 2025), ALNY quarterly depreciation & amortization is $13.94 million, with the most recent change of -$461.00 thousand (-3.20%) on June 30, 2025.
- Over the past year, ALNY quarterly D&A has dropped by -$1.06 million (-7.06%).
- ALNY quarterly D&A is now -7.06% below its all-time high of $15.00 million, reached on June 30, 2024.
Performance
ALNY quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$56.50M-$1.06M(-1.84%)Summary
- As of today (August 25, 2025), ALNY TTM depreciation & amortization is $56.50 million, with the most recent change of -$1.06 million (-1.84%) on June 30, 2025.
- Over the past year, ALNY TTM D&A has increased by +$1.17 million (+2.11%).
- ALNY TTM D&A is now -1.84% below its all-time high of $57.56 million, reached on March 31, 2025.
Performance
ALNY TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ALNY Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4.8% | -7.1% | +2.1% |
| 3 y3 years | -36.8% | +38.1% | +32.3% |
| 5 y5 years | +4.2% | +70.0% | +412.1% |
ALNY Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -36.8% | +27.4% | -7.1% | +38.1% | -1.8% | +36.0% |
| 5 y | 5-year | -36.8% | +27.4% | -7.1% | +70.0% | -1.8% | +412.1% |
| alltime | all time | -36.8% | >+9999.0% | -7.1% | +236.4% | -1.8% | >+9999.0% |
ALNY Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $13.94M(-3.2%) | $56.50M(-1.8%) |
| Mar 2025 | - | $14.40M(+1.7%) | $57.56M(+1.6%) |
| Dec 2024 | $56.67M(+4.8%) | $14.17M(+1.3%) | $56.67M(+1.2%) |
| Sep 2024 | - | $13.98M(-6.8%) | $55.98M(+1.2%) |
| Jun 2024 | - | $15.00M(+11.0%) | $55.33M(+3.4%) |
| Mar 2024 | - | $13.52M(+0.3%) | $53.51M(-1.0%) |
| Dec 2023 | $54.05M(+21.6%) | $13.48M(+1.2%) | $54.05M(-1.5%) |
| Sep 2023 | - | $13.33M(+1.1%) | $54.88M(+5.2%) |
| Jun 2023 | - | $13.18M(-6.3%) | $52.16M(+6.3%) |
| Mar 2023 | - | $14.06M(-1.7%) | $49.07M(+10.4%) |
| Dec 2022 | $44.47M(-50.4%) | $14.31M(+35.0%) | $44.47M(+7.1%) |
| Sep 2022 | - | $10.60M(+5.0%) | $41.53M(-2.8%) |
| Jun 2022 | - | $10.10M(+6.7%) | $42.72M(-3.8%) |
| Mar 2022 | - | $9.46M(-16.8%) | $44.43M(-6.6%) |
| Dec 2021 | $89.69M(+20.5%) | $11.38M(-3.5%) | $47.57M(+2.1%) |
| Sep 2021 | - | $11.79M(-0.2%) | $46.58M(+7.4%) |
| Jun 2021 | - | $11.80M(-6.3%) | $43.37M(+9.1%) |
| Mar 2021 | - | $12.60M(+21.3%) | $39.76M(+14.3%) |
| Dec 2020 | $74.44M(+36.9%) | $10.39M(+21.1%) | $34.77M(+16.6%) |
| Sep 2020 | - | $8.57M(+4.5%) | $29.83M(+170.4%) |
| Jun 2020 | - | $8.20M(+7.7%) | $11.03M(-12.3%) |
| Mar 2020 | - | $7.61M(+39.9%) | $12.58M(-26.8%) |
| Dec 2019 | $54.37M(+256.6%) | $5.44M(-153.2%) | $17.18M(+80.7%) |
| Sep 2019 | - | -$10.22M(-204.9%) | $9.51M(-58.6%) |
| Jun 2019 | - | $9.74M(-20.2%) | $22.97M(+48.5%) |
| Mar 2019 | - | $12.21M(-648.0%) | $15.47M(+140.4%) |
| Dec 2018 | $15.25M(+28.2%) | -$2.23M(-168.6%) | $6.43M(-48.0%) |
| Sep 2018 | - | $3.25M(+45.0%) | $12.38M(-2.7%) |
| Jun 2018 | - | $2.24M(-29.5%) | $12.72M(-6.1%) |
| Mar 2018 | - | $3.18M(-14.4%) | $13.54M(+1.3%) |
| Dec 2017 | $11.90M(-21.4%) | $3.71M(+3.5%) | $13.37M(+5.5%) |
| Sep 2017 | - | $3.59M(+17.0%) | $12.67M(+0.7%) |
| Jun 2017 | - | $3.07M(+2.2%) | $12.58M(-7.0%) |
| Mar 2017 | - | $3.00M(-0.6%) | $13.53M(-10.6%) |
| Dec 2016 | $15.13M(-20.6%) | $3.02M(-13.8%) | $15.13M(-11.9%) |
| Sep 2016 | - | $3.50M(-12.7%) | $17.18M(-9.3%) |
| Jun 2016 | - | $4.01M(-12.8%) | $18.95M(-5.1%) |
| Mar 2016 | - | $4.60M(-9.2%) | $19.96M(+4.8%) |
| Dec 2015 | $19.05M(+59.7%) | $5.07M(-3.8%) | $19.05M(+10.0%) |
| Sep 2015 | - | $5.27M(+5.0%) | $17.32M(+14.2%) |
| Jun 2015 | - | $5.02M(+36.1%) | $15.17M(+16.5%) |
| Mar 2015 | - | $3.69M(+10.4%) | $13.02M(+9.1%) |
| Dec 2014 | $11.93M | $3.34M(+7.2%) | $11.93M(+6.4%) |
| Sep 2014 | - | $3.12M(+8.7%) | $11.21M(+3.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2014 | - | $2.87M(+10.3%) | $10.86M(+1.5%) |
| Mar 2014 | - | $2.60M(-1.0%) | $10.70M(+4.6%) |
| Dec 2013 | $10.23M(+13.2%) | $2.63M(-5.0%) | $10.23M(+6.3%) |
| Sep 2013 | - | $2.76M(+2.0%) | $9.63M(+5.2%) |
| Jun 2013 | - | $2.71M(+27.5%) | $9.15M(+1.2%) |
| Mar 2013 | - | $2.13M(+5.1%) | $9.04M(+0.1%) |
| Dec 2012 | $9.04M(+76.3%) | $2.02M(-11.4%) | $9.04M(+9.5%) |
| Sep 2012 | - | $2.29M(-12.3%) | $8.25M(+14.2%) |
| Jun 2012 | - | $2.60M(+22.8%) | $7.22M(+22.3%) |
| Mar 2012 | - | $2.12M(+71.5%) | $5.91M(+15.3%) |
| Dec 2011 | $5.13M(+3.7%) | $1.24M(-2.0%) | $5.13M(-1.0%) |
| Sep 2011 | - | $1.26M(-1.9%) | $5.18M(-0.1%) |
| Jun 2011 | - | $1.29M(-3.9%) | $5.18M(+1.3%) |
| Mar 2011 | - | $1.34M(+3.7%) | $5.12M(+3.6%) |
| Dec 2010 | $4.94M(-17.5%) | $1.29M(+2.0%) | $4.94M(+3.2%) |
| Sep 2010 | - | $1.27M(+3.5%) | $4.79M(+3.3%) |
| Jun 2010 | - | $1.22M(+5.3%) | $4.63M(-13.5%) |
| Mar 2010 | - | $1.16M(+2.2%) | $5.35M(-10.7%) |
| Dec 2009 | $5.99M(+4.6%) | $1.14M(+2.3%) | $5.99M(-9.9%) |
| Sep 2009 | - | $1.11M(-42.8%) | $6.65M(-7.2%) |
| Jun 2009 | - | $1.94M(+7.8%) | $7.17M(+9.1%) |
| Mar 2009 | - | $1.80M(+0.2%) | $6.58M(+14.9%) |
| Dec 2008 | $5.73M(+40.3%) | $1.80M(+10.2%) | $5.73M(+18.6%) |
| Sep 2008 | - | $1.63M(+21.2%) | $4.83M(+13.7%) |
| Jun 2008 | - | $1.35M(+41.5%) | $4.25M(+10.7%) |
| Mar 2008 | - | $951.00K(+5.4%) | $3.84M(-6.0%) |
| Dec 2007 | $4.08M(+7.0%) | $902.00K(-13.9%) | $4.08M(-4.3%) |
| Sep 2007 | - | $1.05M(+11.8%) | $4.27M(+1.3%) |
| Jun 2007 | - | $937.00K(-21.6%) | $4.21M(-0.2%) |
| Mar 2007 | - | $1.20M(+9.9%) | $4.22M(+10.6%) |
| Dec 2006 | $3.81M(+22.3%) | $1.09M(+9.6%) | $3.81M(+9.6%) |
| Sep 2006 | - | $992.00K(+4.8%) | $3.48M(+7.8%) |
| Jun 2006 | - | $947.00K(+20.0%) | $3.23M(-0.2%) |
| Mar 2006 | - | $789.00K(+4.9%) | $3.23M(+3.7%) |
| Dec 2005 | $3.12M(+27.6%) | $752.00K(+1.6%) | $3.12M(+0.0%) |
| Sep 2005 | - | $740.00K(-22.3%) | $3.12M(+0.4%) |
| Jun 2005 | - | $952.00K(+41.0%) | $3.11M(+19.1%) |
| Mar 2005 | - | $675.00K(-10.1%) | $2.61M(+6.7%) |
| Dec 2004 | $2.44M(+191.6%) | $751.00K(+3.2%) | $2.44M(+44.4%) |
| Sep 2004 | - | $728.00K(+60.4%) | $1.69M(+75.4%) |
| Jun 2004 | - | $454.00K(-11.2%) | $965.00K(+88.8%) |
| Mar 2004 | - | $511.00K | $511.00K |
| Dec 2003 | $838.00K(+2227.8%) | - | - |
| Dec 2002 | $36.00K | - | - |
FAQ
- What is Alnylam Pharmaceuticals, Inc. annual depreciation & amortization?
- What is the all time high annual D&A for Alnylam Pharmaceuticals, Inc.?
- What is Alnylam Pharmaceuticals, Inc. annual D&A year-on-year change?
- What is Alnylam Pharmaceuticals, Inc. quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Alnylam Pharmaceuticals, Inc.?
- What is Alnylam Pharmaceuticals, Inc. quarterly D&A year-on-year change?
- What is Alnylam Pharmaceuticals, Inc. TTM depreciation & amortization?
- What is the all time high TTM D&A for Alnylam Pharmaceuticals, Inc.?
- What is Alnylam Pharmaceuticals, Inc. TTM D&A year-on-year change?
What is Alnylam Pharmaceuticals, Inc. annual depreciation & amortization?
The current annual D&A of ALNY is $56.67M
What is the all time high annual D&A for Alnylam Pharmaceuticals, Inc.?
Alnylam Pharmaceuticals, Inc. all-time high annual depreciation & amortization is $89.69M
What is Alnylam Pharmaceuticals, Inc. annual D&A year-on-year change?
Over the past year, ALNY annual depreciation & amortization has changed by +$2.62M (+4.84%)
What is Alnylam Pharmaceuticals, Inc. quarterly depreciation & amortization?
The current quarterly D&A of ALNY is $13.94M
What is the all time high quarterly D&A for Alnylam Pharmaceuticals, Inc.?
Alnylam Pharmaceuticals, Inc. all-time high quarterly depreciation & amortization is $15.00M
What is Alnylam Pharmaceuticals, Inc. quarterly D&A year-on-year change?
Over the past year, ALNY quarterly depreciation & amortization has changed by -$1.06M (-7.06%)
What is Alnylam Pharmaceuticals, Inc. TTM depreciation & amortization?
The current TTM D&A of ALNY is $56.50M
What is the all time high TTM D&A for Alnylam Pharmaceuticals, Inc.?
Alnylam Pharmaceuticals, Inc. all-time high TTM depreciation & amortization is $57.56M
What is Alnylam Pharmaceuticals, Inc. TTM D&A year-on-year change?
Over the past year, ALNY TTM depreciation & amortization has changed by +$1.17M (+2.11%)